Fundraising FoxGoldfinch BioPharma
Cambridge, US · Founded 2015 · Delaware corporation · 2 known investors
Find your way into Goldfinch BioPharma
Sign up to see every warm intro you have to Goldfinch BioPharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Goldfinch BioPharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PT
PETER THOMSONExecutive
Board
AC
NE
LB
LOUIS BRENNERBoard director
Investors · 2
Third Rock VenturesreportedBoston · $100K – $5Mvia Abbie Celniker · board
How we know: board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$69.7M disclosed across 2 rounds · 2016–2020
▶$69.7MraisedJul 2020 · 26 investors · PharmaceuticalsRule 506(b)
▶$69.7MraisedJul 2020 · 26 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- ABBIE CELNIKERDirector
- JOY GHOSHDirector
- ANTHONY JOHNSONExecutive Officer, Director
- NEIL EXTERDirector
- WEN CHENDirector
- FRANK CZERWIECExecutive Officer
- LORI RUDOLPH-OWENExecutive Officer
- KYLE KUVALANKAExecutive Officer
- CURTIS DEMICKExecutive Officer
- JEAN-CHRISTOPHE HARMANGEExecutive Officer
- LOUIS BRENNERDirector
- FRANK MADDUXDirector
- Amount sold
- $69.7M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$596raisedJan 2017 · 20 investors · Other Health CareRule 506(b)
▶$596raisedJan 2017 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- ABBIE CELNIKERExecutive Officer, Director
- LOUIS BRENNERDirector
- NEIL EXTERExecutive Officer, Director
- PETER THOMSONExecutive Officer
- Offering amount
- $596
- Amount sold
- $596
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Goldfinch BioPharma's investors?
- Goldfinch BioPharma's investors include Third Rock Ventures, Wellington Management.
- How much funding has Goldfinch BioPharma raised?
- Goldfinch BioPharma has disclosed $69.7M raised across 2 rounds.
- Where is Goldfinch BioPharma headquartered?
- Goldfinch BioPharma is headquartered in Cambridge, US.